1. Dissociation between the pharmacokinetics and pharmacodynamics of once‐daily rivaroxaban and twice‐daily apixaban: a randomized crossover study. (14th September 2017) Authors: Kreutz, R.; Persson, P. B.; Kubitza, D.; Thelen, K.; Heitmeier, S.; Schwers, S.; Becka, M.; Hemmrich, M. Journal: Journal of thrombosis and haemostasis Issue: Volume 15:Number 10(2017) Page Start: 2017 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗